Direct-to-Consumer Platforms for New Antiobesity Medications - Concerns and Potential Opportunities
N Engl J Med
.
2024 Feb 22;390(8):677-680.
doi: 10.1056/NEJMp2312816.
Epub 2024 Feb 17.
Authors
Ilya Golovaty
1
,
Scott Hagan
1
Affiliation
1
From the VA Puget Sound Health Care System (I.G., S.H.), and the Division of General Internal Medicine, University of Washington (I.G., S.H.) - both in Seattle.
PMID:
38375888
DOI:
10.1056/NEJMp2312816
No abstract available